| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| R794158 | MACKLIN | 维生素A酸 | 10mM in DMSO | 326元/1ml; | 咨询 |
|
| R817256 | MACKLIN | 维生素A酸 | 分析对照品, ≥98.5%(HPLC) | 596元/250mg; | 咨询 |
|
| R817255 | MACKLIN | 维生素A酸 | 98% | 30元/500mg; 34元/1g; 86元/5g; 324元/25g; 1118元/100g; 4539元/500g; | 咨询 |
|
| R0064 | TCI | Retinoic Acid | >93.0%(HPLC) | 760元/1G; 2630元/5G; | 咨询 |
基本信息 | 纯度/分析方法 | >93.0%(HPLC) | | 分子式/分子量 | C20H28O2 = 300.44 | | 外观与形状(20℃) | 固体 | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 光,空气 | | Reaxys-RN | 2057223 | | PubChem物质ID | 87575622 | | SDBS (AIST Spectral DB) | 21421 | | Merck Index (14) | 8165 | | MDL编号 | MFCD00001551 |
技术规格 | Appearance | Light yellow to Amber to Dark green powder to crystal | | Purity(HPLC) | min. 93.0 area% | | Purity(Neutralization titration) | min. 98.0 % |
物性(参考值) | 熔点 | 180 ℃ | | 水溶性 | 不溶 | | 溶解性(可溶于) | 乙醚 | | 溶解性(微溶于) | 醇 |
安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。 H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。 P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。
|
相关法规 |
| 257957 | J&K | Retinoic Acid | 97% | 94元/100MG; 686元/1G; 2498元/5G; | 咨询 |
基本信息 | 分子式 | C20H28O2 | | 分子量 | 300.44 | | 熔点 | 180-181 | | MDL编码 | MFCD00001551 | | Beilstein | 2057223 | | Merck | 14,8165 | | EINECS 编号 | 206-129-0 | | 存储条件 | Freezer -20℃ |
安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H302 H411 | | 防范说明 | P273 | | WGK | 2 | | RTECS | VH6475000 | | TSCA | 是 |
|
| 961027 | J&K | Retinoic Acid | 98.5%, RAR核受体的天然激动剂, 对RARα/β/γ的IC50为14 nM, 与 PPARβ/δ 结合的Kd值为17 nM | 99元/100MG; 219元/250MG; 722元/1G; | 咨询 |
基本信息 | 分子式 | C20H28O2 | | 分子量 | 300.44 | | 熔点 | 180-181 | | MDL编码 | MFCD00001551 | | Beilstein | 2057223 | | Merck | 14,8165 | | EINECS 编号 | 206-129-0 | | 存储条件 | Freezer -20℃ | 产品描述 Tretinoin,是 Retinoic acid receptor (RAR) 和Retinoid X receptor (RXR)的配体,作用于急性早幼粒细胞白血病(APL)细胞,诱导粒细胞分化和凋亡。 靶点(IC50 & Targe) RAR 体外研究 Tretinoin通过增加过氧化氢酶活性和还原型谷胱甘肽含量,防止培养的人肾小球系膜细胞中H2O2的细胞毒性,其随剂量和时间改变。Tretinoin培育的系膜细胞导致过氧化氢酶mRNA和γ-谷酰基-半胱氨酸合成酶(催化亚基) mRNA水平增加,后者在还原型谷胱甘肽从头合成中是限速步骤。[1] Tretinoin上调人瘢痕疙瘩衍生的成纤维细胞中基质金属蛋白酶-13和基质金属蛋白酶-8. [2] 体内研究 Tretinoin处理的老年雄性Fischer 344大鼠肾皮质中蛋白质含量比对照组老年大鼠低30%,这种作用可能依赖于对肿瘤坏死因子-β1(一种matrigenic细胞因子)和骨桥蛋白(一种具有细胞吸附和趋药性的蛋白质)表达的抑制。[1]在无毛小鼠真皮结缔组织,Tretinoin能够防止主要类固醇引起的生物力学改变,其有助于萎缩。[3]在豚鼠体内,Tretinoin与imiquimod结合导致组织病理学上的纹身褪色和色素间隙适度。[4]在45 CD-1小鼠的皮肤切口上,Tretinoin增加成纤维细胞的分化,但是胶原蛋白的产生量减少。[5] 参考文献 [1] Manzano VM, et al. J Pharmacol Exp Ther, 1999, 289(1), 123-132. [2] Uchida G, et al. Exp Dermatol, 2003, 12 ,Suppl 2, 35-42. [3] Schwartz E, et al. J Invest Dermatol, 1994, 102(2), 241-246. [4] Solis RR, et al. Dermatol Surg, 2002, 28(1), 83-6, discussion 86-87. [5] Muehlberger T, et al. J Am Acad Dermatol, 2005, 52(4), 583-5 安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H302 H411 | | 防范说明 | P301+P312+P330 | | WGK | 2 | | RTECS | VH6475000 | | TSCA | 是 |
|
| 044540 | Alfa Aesar | Retinoic Acid | 97% | 469元/0.1g; 1242元/0.5g; 4112元/2g; | 咨询 |
应用 Retinoic acid is used in dermatology drugs. It is used in the treatment of psoriasis, ichthyosis, follicular keratosis, acne, lichen planus, verrucous epidermal nevus and lichen psoriasis. It is also employed in promoting the proliferation and differentiation of epithelial cells. In addition to this, it exhibits some preventive effect on skin cancer. 备注 Light sensitive. Store in a cool place. Incompatible with oxidizing agents. 基本信息 MDL MFCD00001551 EINECS 206-129-0 分子式 C20H28O2 分子量 300.44 熔点 180-182° 灵敏度 Light Sensitive. Ambient temperatures. 形态 Crystalline 溶解性 Soluble in ethanol, acetate, dimethyl formamide, dimethyl sulfoxide, chloroform, methanol, acetone and dichloromethane. Insoluble in water and ether. Beilstein 2057223 Merck 14,8165 GHS危害和防范说明 GHS符号
  Hazard Statements H302-H361 Harmful if swallowed.Suspected of damaging fertility or the unborn child. Precautionary Statements P201-P280-P301+P312a-P308+P313-P405-P501a Obtain special instructions before use.Wear protective gloves/protective clothing/eye protection/face protection.Wear protective gloves/protective clothing/eye protection/face protection.IF exposed or concerned: Get medical advice/attention.Store locked up.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 危险类别 22-63 Harmful if swallowed.Possible risk of harm to the unborn child. 安全等级 36/37-60 Wear suitable protective clothing and gloves.This material and its container must be disposed of as hazardous waste 欧盟危险品标志
 RTECS VH6475000 TSCA 是 |
| C20734 | Alfa Aesar | all-trans-Retinoic Acid | 97% | 919元/100mg; 3506元/1g; 14712元/5g; | 咨询 |
基本信息 Ref# 20734 MDL 1551 分子式 C20 H28 O2 分子量 300.44 |
| 1674004 | USP | Tretinoin | United States Pharmacopeia (USP) Reference Standard | 3231.47元/5 X 30 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 all−trans−视黄酸(ATRA)是视黄酸受体(RAR)和类视黄醇X受体(RXR)的一种配体。所结合的RAR和RXR可作为调节正常细胞和恶性细胞的生长和分化的转录因子。细胞色素P450(CYP)可催化ATRA的4-羟基化。视黄酸可使胚胎干细胞成为神经元。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H28O2 | | 分子量 | 300.44 | | Beilstein | 2057223 | | MDL编号 | MFCD00001551 | | PubChem化学物质编号 | 329751371 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | 180-181 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1 | | InChI | 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+ | | InChI key | SHGAZHPCJJPHSC-YCNIQYBTSA-N | | Gene Information | human ... RARA(5914), RARB(5915), RARG(5916) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 | | 预防措施声明 | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P332 + P313 | | 危险分类 | Acute Tox. 4 Oral - Skin Irrit. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| T1850000 | | Tretinoin | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the authority of the issuing pharmacopoeia. For further information and support please go to the website of the issuing pharmacopoeia. Tretinoin is a medication used to treat a variety of skin conditions such as photodamaged skin, acne, etc. It is used as an anti-aging product and also as an oral treatment for leukemia. 应用 Tretinoin may be used as an analytical reference standard for the quantification of the analyte in dermatological formulations using high-performance liquid chromatography technique. 生化/生理作用 all−trans−视黄酸(ATRA)是视黄酸受体(RAR)和类视黄醇X受体(RXR)的一种配体。所结合的RAR和RXR可作为调节正常细胞和恶性细胞的生长和分化的转录因子。细胞色素P450(CYP)可催化ATRA的4-羟基化。视黄酸可使胚胎干细胞成为神经元。 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H28O2 | | 分子量 | 300.44 | | Beilstein | 2057223 | | MDL编号 | MFCD00001551 | | PubChem化学物质编号 | 329826691 | | NACRES | NA.24 |
产品性质 | 生物来源 | synthetic | | 等级 | pharmaceutical primary standard | | agency | EP | | 形式 | solid | | manufacturer/tradename | EDQM | | technique(s) | gas chromatography (GC): suitable liquid chromatography (LC): suitable | | mp | 180-181 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1 | | InChI | 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+ | | InChI key | SHGAZHPCJJPHSC-YCNIQYBTSA-N | | Gene Information | human ... RARA(5914), RARB(5915), RARG(5916) |
安全信息 | 象形图 |    | | 警示用语: | Danger | | 危险声明 | H302 - H315 - H360FD - H410 | | 预防措施声明 | P202 - P264 - P273 - P301 + P312 - P302 + P352 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B - Skin Irrit. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| R2625 | Sigma-Aldrich | Retinoic Acid | ≥98% (HPLC), powder | 349.34元/50 MG; 488.82元/100 MG; 1318.18元/500 MG; 2377.5元/1 G; 10963.9元/5 G; | 咨询 |
产品说明 应用 - 视黄酸(RA)已用于胚胎干细胞至运动神经元的分化。
- 它已用于非洲爪蟾外胚层至胰腺的分化。
- 它还用于研究由RARα (视黄酸受体α)引起的表观遗传学调控。
- 它已用于研究原初精原细胞向精母细胞转化的RA信号转导。
包装 1, 5 g in ampule 50, 100, 500 mg in ampule 生化/生理作用 all−trans−视黄酸(ATRA)是视黄酸受体(RAR)和类视黄醇X受体(RXR)的一种配体。所结合的RAR和RXR可作为调节正常细胞和恶性细胞的生长和分化的转录因子。细胞色素P450(CYP)可催化ATRA的4-羟基化。视黄酸可使胚胎干细胞成为神经元。 特点和优势 该化合物是受体分类及信号转导手册上核受体(非类固醇)页面上的特色化合物。如需浏览其他手册页面,请点击此处。 其他说明 Scripps Center for Metabolomics(斯克里普斯代谢组学中心)独立生成的串联质谱数据,可以PDF格式查看或下载。 R2625.pdf 经过测试的代谢物在Scripps Center for Metabolomics(斯克里普斯代谢组学中心) METLIN 代谢物数据库中有重点介绍。更多信息请见sigma.com/metlin。 基本信息 | 经验(实验)分子式 | C20H28O2 | | 分子量 | 300.44 | | Beilstein | 2057223 | | EC 号 | 206-129-0 | | MDL编号 | MFCD00001551 | | PubChem化学物质编号 | 24278674 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 生物来源 | synthetic (organic) | | 测定 | ≥98% (HPLC) | | 形式 | powder | | technique(s) | cell culture | mammalian: suitable | | 颜色 | yellow | | mp | 180-181 ℃ (lit.) | | 储存温度 | −20℃ | | SMILES string | CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1 | | InChI | 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+ | | InChI key | SHGAZHPCJJPHSC-YCNIQYBTSA-N | | Gene Information | human ... RARA(5914), RARB(5915), RARG(5916), RXRA(6256), RXRB(6257), RXRG(6258) mouse ... Rara(19401), Rarb(218772), Rarg(19411), Rxrb(20182) |
安全信息 | 象形图 |    | | 警示用语: | Danger | | 危险声明 | H302 - H315 - H360FD - H410 | | 预防措施声明 | P202 - P264 - P273 - P301 + P312 - P302 + P352 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B - Skin Irrit. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| PHR1187 | Supelco | Tretinoin | Pharmaceutical Secondary Standard; Certified Reference Material | 1904.93元/3 X 100 MG; | 咨询 |
产品说明 一般描述 用于质量控制的已认证的药物二级标准,为制药实验室和制造商提供了药典基本标准的一种方便且成本效益好的替代品。维A酸一种用于治疗严重囊肿型痤疮的药物。该药物通过调节上皮细胞的生长和分化、皮脂的产生、胶原蛋白的合成和皮肤的角质化作用来发挥作用。 应用 维A酸可用作药物参考标准品,用于通过色谱技术测定药物制剂中的分析物。 这些二级标准品是经过检验的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他标定应用。 生化/生理作用 all−trans−视黄酸(ATRA)是视黄酸受体(RAR)和类视黄醇X受体(RXR)的一种配体。所结合的RAR和RXR可作为调节正常细胞和恶性细胞的生长和分化的转录因子。细胞色素P450(CYP)可催化ATRA的4-羟基化。视黄酸可使胚胎干细胞成为神经元。 分析说明 这些二级标准品可追溯至USP、EP(PhEur)和BP一级标准品。 其他说明 该认证标准物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。 附注 要查看该材料的分析证书示例,请在下面的栏位中输入LRAB7354。这只是一个示例证书,可能不是您收到的批次。 基本信息 | 经验(实验)分子式 | C20H28O2 | | 分子量 | 300.44 | | Beilstein | 2057223 | | EC 号 | 206-129-0 | | MDL编号 | MFCD00001551 | | PubChem化学物质编号 | 329823197 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | 形式 | solid | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | mp | 180-181 ℃ (lit.) | | application(s) | food and beverages | | 格式 | neat | | 药典可追溯性 | traceable to PhEur T1850000 traceable to USP 1674004 | | 储存温度 | -10 to -25℃ | | SMILES string | CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1 | | InChI | 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+ | | InChI key | SHGAZHPCJJPHSC-YCNIQYBTSA-N | | Gene Information | human ... RARA(5914), RARB(5915), RARG(5916) |
安全信息 | 象形图 |    | | 警示用语: | Danger | | 危险声明 | H302 - H315 - H360FD - H410 | | 预防措施声明 | P202 - P264 - P273 - P301 + P312 - P302 + P352 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B - Skin Irrit. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 554720 | Millipore | trans-Retinoic Acid-CAS 302-79-4-Calbiochem | Potent modulator of growth and differentiation. Inhibits melanocyte adhesion, motility, and growth. | 1594.69元/500 MG; | 咨询 |
产品说明 一般描述 Potent modulator of growth and differentiation. Exerts its effects by binding to nuclear retinoic acid receptors (RARs) which directly regulate gene expression. Inhibits melanocyte adhesion, motility, and growth. Has keratolytic activity. Induces differentiation of tumor cells of neural origin. Induces apoptosis in acute promyelocytic carcinoma cells. Potent modulator of growth and differentiation. Exerts its effects by binding to nuclear retinoic acid receptors (RARs) which directly regulate gene expression. Inhibits melanocyte adhesion, motility, and growth. Has keratolytic activity. Induces differentiation of tumor cells of neural origin. Induces apoptosis in acute promyelocytic carcinoma cells. PROTECT FROM AIR. 包装 500 mg in Glass bottle Packaged under inert gas 警告 Toxicity: Harmful & Carcinogenic / Teratogenic (E) 重悬 Following reconstitution, store in the refrigerator (4°C). DMSO stock solutions are stable for up to 2 weeks at 4°C. 其他说明 Tosi, P., et al. 1994. Leuk. Lymphoma14, 503. Clagett-Dame, M., et al. 1993. Arch. Biochem. Biophys.300, 684. Labbaye, C., et al. 1993. Blood81, 475. Sakashita, A., et al. 1993. Blood81, 1009. Situ, R., et al. 1993. Dermatology186, 38. Tini, M., et al. 1993. Genes Develop.7, 295. Leid, M., et al. 1992. Trends Biochem. Sci.17, 427. Sharpe, C.R. 1991. Neuron7, 239. Thaller, C. and Eichele, G. 1990. Nature345, 815. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息 | 经验(实验)分子式 | C20H28O2 | | 分子量 | 300.44 | | MDL编号 | MFCD00001551 |
产品性质 | 质量水平 | 100 | | 测定 | ≥95% (by assay) | | 形式 | solid | | manufacturer/tradename | Calbiochem® | | 储存条件 | OK to freeze desiccated (hygroscopic) protect from light | | 颜色 | yellow | | 溶解性 | DMSO: 25 mg/mL | | 运输 | ambient | | 储存温度 | 2-8℃ | | InChI | 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+ | | InChI key | SHGAZHPCJJPHSC-YCNIQYBTSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 | | 预防措施声明 | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P332 + P313 | | 危险分类 | Acute Tox. 4 Oral - Skin Irrit. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 317904 | Fluorochem | (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid | 98% | 220元/1g; 704元/5g; 1188元/10g; 2376元/25g; | 咨询 |
基本信息 | CAS Number | 302-79-4 | | MDL Number | MFCD00001551 |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|